This site is intended for Healthcare Professionals only.

DHSC re-classifies all Madopar preparations as special containers

Date:

Share post:

The Department of Health of Social Care (DHSC) has re-determined that all six Madopar (Co-beneldopa) preparations meet the special container criteria as outlined in Part II Clause 10 of the Drug Tariff.

“The NHS dictionary of medicines and devices (dm+d) has now been updated with special container status applied to the complete pack sizes of all Madopar preparations,” said PSNC.

“The special container rules apply immediately to all branded or generically written prescriptions for Madopar dispensed from December 2022 onwards.”

The following products will be treated as special containers for prescriptions dispensed from December 2022 onwards:

Brand and/or Manufacturer Generic drug name (dm+d descriptor) Pack size Special container
Madopar® 50mg/12.5mg capsules (Roche Products Ltd) Co-beneldopa 12.5mg/50mg capsules 100 Complete pack
Madopar® 50mg/12.5mg dispersible tablets (Roche Products Ltd) Co-beneldopa 12.5mg/50mg dispersible tablets sugar free 100 Complete pack
Madopar® 100mg/25mg capsules (Roche Products Ltd) Co-beneldopa 25mg/100mg capsules 100 Complete pack
Madopar® 100mg/25mg dispersible tablets (Roche Products Ltd) Co-beneldopa 25mg/100mg dispersible tablets sugar free 100 Complete pack
Madopar® CR capsules (Roche Products Ltd) Co-beneldopa 25mg/100mg modified-release capsules 100 Complete pack
Madopar® 200mg/50mg capsules (Roche Products Ltd) Co-beneldopa 50mg/200mg capsules 100 Complete pack


Roche commented:“Over the last few years pharmacists had been raising the challenges they were facing when dispensing Madopar according to its Summary of Product Characteristics (SmPC). Consequently, we proactively approached the Pharmaceutical Services Negotiating Committee (PSNC) to collaborate on a solution that would rectify the situation. We are delighted for Pharmacies and the patients they serve that the NHS Business Services Authority has awarded Madopar special container status.”

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

NHS supply chain appoints Richard Evans as commercial executive director

Experienced leader to drive transformation in healthcare supply chain through new NHS  appointment NHS Supply Chain today announced the...

UK launches Critical Imports Council to secure supplies of medicines, smartphone chips

The Council aims to address the supply challenges businesses face and develop real-life solutions The UK government has...

Health secretary accuses NHS gender care influenced by ‘cultural values’

Wes Streeting challenges plans for improving mental health assessments amidst growing scrutiny over NHS gender care  In a...

Health inequalities in England: Major illness rate significantly higher in deprived areas

The Health Foundation report predicts that 80% of the increase in major illness among working-age people will be...